Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.2 EUR | +2.12% | +12.71% | +142.32% |
29/05 | Baird Starts Mind Medicine (MindMed) With Outperform Rating, $27 Price Target | MT |
13/05 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MIND MEDICINE (MINDMED) INC. | Other Biotechnology & Medical Research | +2.12% | +12.71% | +142.32% | +153.56% | - | 632M | - | - | - |
- Stock Market
- Equities
- MNMD Stock
- MMQ Stock
- Charts Mind Medicine (MindMed) Inc.
- Relative Strength Chart